The green synthesis of zinc sulfide nanoparticles (ZnS NPs)-mediated plant extract is gaining importance because of its simplicity, cost-effectiveness, and ecofriendly nature. In this work, ZnS NPs were synthesized using garlic extract as NPs facilitating agent, characterized by Fourier transform infrared, X-ray diffraction, scanning electron microscope, and UV–visible, then their antibacterial and hemocompatibility were assayed. Analysis revealed a cubic phase, 2.33 nm crystallite size, and a 3.75 eV optical bandgap. Bioactivity test against Staphylococcus aureus and Escherichia coli indicated dose-dependent potency closer to that of azithromycin standard drug and more efficient on S. aureus (Gram-positive) than E. coli (Gram-negative) bacteria. Biocompatibility test in terms of erythrocyte hemolysis, in reference to normal saline and water as minimal and maximal controls, confirmed nontoxic substance up to 100 μg/mL as the highest examined concentration and at which a lysis of 2.9% was detected. Therefore, it could be concluded that this biogenic method is effective in producing ZnS NPs with desirable properties for potential biomedical applications.
In the present study, the sol-gel method has been utilized to synthesize tri-phase CuO-Fe2O3-MgOnanocomposites (NCs) by employing tartaric acid (TA) as an organic fuel. The obtained NCs were characterized using XRD, SEM, FTIR, and UV-Vis. The XRD pattern asserted the formation of NCs with MgO (cubic), CuO (monoclinic), and Fe2O3 (hexagonal) crystals. The crystallite size (Dav) was calculated by Scherrer's formula, whereas the optical properties were assessed using UV-Vis spectra. The optical band gap values of the synthesized materials displayed variations related to tartaric acid concentration due to the quantum confinement of tri-metal oxide NCs. The SEM described the morphological properties and FTIR confirmed the formation of interfaces among the metal oxides CuO, Fe2O3 and MgO in the NCs. The enhanced optical properties of these tri-metal oxide NCs make them a good candidate for optoelectronic applications.
Multi-phase metal oxides nanocomposites (NCs) have attracted considerable attention due to their extraordinary properties and novel applications over monometallic ones. Hence, trimetallic oxides nanoparticles (NPs) are preferred because of their immensely improved optical, catalytic, and biological properties, but few materials have been reported. Besides, glycine is an excellent structure-directing agent for NPs production with tailored physicochemical properties. Thus, in this work, a novel tri-phase CuO–Fe2O3–MgO (1:1:1) NCs was prepared via a sol-gel method in the presence of glycine as a fuel. The obtained NCs were characterized by Fourier transmission infrared, X-ray diffraction (XRD), Scanning electron micrographs, and UV-Vis. The XRD analysis emphasized the formation of NCs with monoclinic CuO, cubic MgO, hexagonal Fe2O3, and tetragonal CuFe2O4 crystals. The average crystallite size (D) was in the order of 10th of nm as computed by Scherrer method, with ternary phase seemingly affect the straightforward influence of glycine fuel concentration on the final crystallite sizes. UV-Vis analysis indicates two optical energy bandgaps which increased as glycine concentration increase. The antibacterial test against Staphylococcus aureus and Escherichia coli bacteria revealed comparable activity to that of Azithromycin standard drug, which increased with glycine concentration increase. The glycine-based tailored structural, optical, and biological properties of such trimetallic NCs making them of considerable candidate for certain applications development, possibly electronics and antibiotics; a case that encourage further investigations.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.